Narcolepsy with hypocretin deficiency is known to alter cardiovascular control during sleep, but its aetiology is disputed. As cardiovascular control differs between sleep states, and narcolepsy affects sleep architecture, controlling for both duration and transitions of sleep states is necessary. This study therefore aimed to assess heart rate and its variability in narcolepsy during sleep taking these factors into account. The study included 12 medication-na€ ıve patients with narcolepsy with cataplexy and hypocretin deficiency (11 male, 16-53 years old), and 12 sex-and age-matched healthy controls (11 male, 19-55 years). All subjects underwent 1-night ambulatory polysomnography recording. Cardiovascular parameters were calculated for each 30-s epoch. Heart rate was significantly higher in patients with narcolepsy than in controls in all sleep states and during wakefulness prior to sleep. Groups did not differ in heart rate variability measures. The effects of sleep state duration on heart rate and its variability were similar between patients and controls. In conclusion, heart rate was consistently higher in patients with narcolepsy than controls, independent of sleep stage and sleep fragmentation. A direct effect of hypocretin deficiency therefore seems probable.
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IN TROD UCTI ON
Narcolepsy with cataplexy (NC) is a chronic disabling sleep disorder, with core symptoms including excessive daytime sleepiness, cataplexy, sleep paralysis, hypnagogic hallucinations and a disturbed nocturnal sleep (Overeem et al., 2001) . Patients with NC are more obese than healthy controls (Kok et al., 2003) . NC is associated with deficiency of the neuropeptide hypocretin (Peyron et al., 2000) , also called 'orexin'. Hypocretin is solely produced in the lateral hypothalamus and plays an important role in sleep/wake regulation (Tsujino and Sakurai, 2009) . Hypocretin also affects thermoregulatory and cardiovascular control (Kukkonen et al., 2002) . Heart rate (HR) and blood pressure during sleep were altered in hypocretin-deficient rodents (Bastianini et al., 2011; Lo Martire et al., 2012; Schwimmer et al., 2010) .
However, these findings are not consistent (Fronczek and Thijs, 2013) : while one study reported a decreased blood pressure with an unaltered HR in hypocretin neuron-ablated transgenic rats (Schwimmer et al., 2010) , others found an elevated blood pressure along with an increased HR in transgenic and knockout mice (Bastianini et al., 2011; Lo Martire et al., 2012) .
Human case-control studies in NC indicated that: (i) HR during nocturnal sleep was continuously elevated (Grimaldi et al., 2012; Silvani et al., 2013; Sorensen et al., 2013) , except for two studies (Donadio et al., 2014; Ferinistrambi et al., 1997) ; (ii) the normal nocturnal decrease in blood pressure was less marked (Dauvilliers et al., 2012; Grimaldi et al., 2012) ; and (iii) HR increased less in response to arousal (Sorensen et al., 2013) and leg movements (Dauvilliers et al., 2011; Sorensen et al., 2013) .
Because arousal increases HR and blood pressure, and as sleep architecture in NC is highly fragmented, these cardiovascular changes may be explained through frequent arousals and sleep state changes in NC (Grimaldi et al., 2012) . Alternatively, hypocretin deficiency itself may directly affect central autonomic control (Grimaldi et al., 2014; Silvani et al., 2013) . To better understand the role of the hypocretin system on HR control in NC, this study aimed to dissect the effects of hypocretin deficiency per se and altered sleep architecture. This study analysed HR and HR variability (HRV) during nocturnal sleep in hypocretin-deficient patients with NC and healthy controls taking duration and transitions of sleep stages into account.
MATERI ALS AND METHODS

Participants
Healthy controls and patients with NC were selected from the Leiden University Medical Centre sleep study database. All participants had undergone a 1-night ambulatory polysomnography (PSG). NC cases were included if they: (i) fulfilled the International Classification for Sleep Disorders -second edition criteria (ICSD-2); (ii) had no detectable level of hypocretin-I in their cerebrospinal fluid (conforming to a level below 50 pg mL À1 ); (iii) had not used and were not using medication for narcolepsy symptoms at the time of the PSG. Each patient was matched for sex and age (AE5 years) to one healthy control. Controls were recruited through an advertisement in local newspapers (Biermasz et al., 2011; Van Hulsteijn et al., 2014) . None of the controls suffered from a sleeping disorder or relevant psychiatric or medical conditions. Exclusion criteria for both groups included age below 16 years, a body mass index (BMI) over 31 kg m À2 , an apnoea/hypopnoea index higher than 10, the use of hypnotics or drugs affecting HR, a history of diabetes mellitus, and pregnancy. The study protocol was approved by the local medical ethics committee, and written informed consent was obtained from the healthy controls. According to Dutch law, no individual informed consent is required from patients if the data analysed were obtained exclusively in the context of patient care, which was the case here.
Study protocol
PSG
Ambulatory PSG was recorded according to standard procedures (Vansweden et al., 1990) (Iber et al., 2007) . All PSG exams in patients with NC were scored as part of the diagnostic evaluation; technicians were therefore unaware of the final diagnosis. The technicians were unblinded when scoring PSG data in healthy controls. Only the nocturnal sleep period and quiet wakefulness (15 min of wakefulness prior to lights off) were selected for analysis.
Electrocardiography and respiration
A continuous wavelet transform analysis was implemented in Matlab (Version 13.1; Mathworks, Natick MA, USA) to detect R-peaks in the electrocardiogram (Legarreta et al., 2005) . Prior to analysis, a visual inspection of the quality of the signal was performed. A filter was used to exclude outliers, defined as values that differed more than 25 beats per minute from the previous or next sample. The resulting time series of RR-intervals were used for further analysis. The mean HR of each epoch was calculated. HRV parameters were derived as follows. A frequency spectrum per epoch was calculated using a fast Fourier transform. The low frequency (LF; 0.04-0.15 Hz) and high frequency (HF; 0.15-0.4 Hz) power components were calculated from the power spectra. The HF component is considered to represent vagal activity, and the LF component to reflect sympathetically mediated baroreflex activity. The LF/HF ratio was computed to be used as a reflection of the sympathovagal balance (Somers et al., 1993) . The total power in the 0-0.4 Hz range was calculated. An increase in total power is generally related to a decline in sympathetic tone (Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Heart Rate Variability, 1996).
As the HF peak is largely determined by respiratory frequency, HF results can be influenced by differences in respiratory frequency (Fig. 1) . The sympathovagal balance was therefore also assessed in a second way, in which the individual respiratory frequency was used to define the HF bandwidth. Respiratory frequency for each epoch was derived from thoracic respiratory band movements. The lower limit of the respiratory frequency power component (HF RF ) was calculated by 0.65 9 respiratory frequency (Hz), and the upper limit by 1.35 9 respiratory frequency (Hz; Aysin and Aysin, 2006) . The LF/HF RF ratio was calculated. Heart rate, LF/HF ratio, LF/HF RF ratio, total power of HRV, and respiratory frequency were calculated for sleep stages 1 and 2, SWS, REM sleep, and quiet wakefulness. All epochs of sleep following onset of nocturnal sleep and prior to awakening in the morning, and all epochs during quiet wakefulness were included in our analysis. To account for the autonomic effects of arousals, this study identified all epochs that coincided with apnoea or leg movements. In addition, we labelled an epoch with 'arousal transition' when this epoch followed a transition from SWS to sleep stage 2 or 1, and from sleep stage 2 to 1.
Sleep parameters
Effects of sleep state duration on HR and HRV
This study first identified all 'periods' of a sleep stage: this is a series of consecutive epochs of a particular sleep stage. The duration of such periods will likely vary considerably within and between subjects. Including all epochs would result in a large number of epochs immediately following a state shift and a progressively lower number of epochs as the duration of the sleep stage becomes lower. To avoid this problem, we chose a specific duration for each sleep stage. The method chosen to define that period was based on the median duration of all periods of that stage. In view of expected differences in duration between cases and controls, this study calculated the median duration separately for the NC and the control group. The shortest of both values was applied to both groups and used for analysis. Periods with a shorter duration than the median value were omitted from analysis, and periods with longer duration were included, but only the part until the defined cut-off value. This analysis could result in differences in numbers of periods that subjects contributed to the analysis, so the number of periods per subject was tabulated to check for any such bias. As only relative minor interindividual differences were seen in this number (Table S1 ), we used the group median duration for the analysis. For each period the temporal order of epochs was recorded (first, second, third, etc.) and included as the variable 'epoch order' to assess the effects of sleep state duration. 
HR and HRV during sleep state transitions
Two types of sleep stage transitions were defined for this analysis: the first was the point between epochs where sleep stages changed from any non-(N)REM state (1, 2 or SWS) to REM sleep. To analyse these transitions, we compared HR and LF/HF ratio during all epochs within a period of 5 min before transition with all epochs within a period of 5 min after transition. The second type of change concerned transitions from any NREM state to the waking state; the analysis was similar except for the duration of the pre-and post-transition periods, which was set to 2 min. For both types of transitions, epochs were labelled as either pre-or post-transition; this factor was used in our analysis of sleep state transitions.
Statistics
The Mann-Whitney U-test was used to assess group differences in baseline characteristics and sleep parameters.
Mixed effect regression models were used to analyse the effect of sleep state, sleep state duration and transitions on cardiovascular parameters. NC, BMI, leg movements, apnoea events and arousal transitions were selected as fixed effects and participants as random effect. An interaction between NC and sleep state was added to the model to assess whether differences between cases and controls varied across sleep states. Random effect variances were computed per group and per sleep state. Likelihood ratio tests were performed to obtain the best model. For the analysis of the effects of sleep state duration, we added the fixed factor epoch order and its interaction with NC to the model. For the effect of sleep state transitions, the fixed factor pre-versus post-transition and its interaction with NC were added to the model. P-values below 0.05 were considered significant. All analyses were performed using the software package R (Version 3.0.0; R Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Participant characteristics and sleep parameters
No group differences were found in mean age and BMI (Table 1) .
As expected, patients with NC had a shorter REM latency, and higher LM and PLM indices. Total sleep time, latency to sleep stage 1, apnoea/hypopnoea index and arousal transitions index did not differ between groups. Sleep architecture in patients with NC was characterized by a higher percentage of sleep stage 1, a higher stage shift index and a lower percentage of SWS. The relative duration of sleep stage 2 and REM sleep did not differ between groups.
HR, HRV and respiratory parameters
HR, HRV and respiratory frequency per sleep state
Overall this study included an average total number of 860 epochs per participant. Cardiovascular parameters were significantly affected by sleep state, leg movements, apnoea and arousal transitions (Table 2) . These variables were included as covariates in the main mixed effect regression model. Age, BMI, and the interaction between NC and sleep state did not significantly influence HR or HRV, and were omitted from the model.
Heart rate was significantly increased in patients with NC, but LF/HF ratio and total power of HRV were similar between groups (Fig. 1) . The increase in HR in the narcolepsy group 
Effects of sleep state duration on HR and HRV
Patients with NC had the shortest median duration of sleep stage 2 (3.5 min versus 4.5 min in controls) and REM sleep (5 min versus 6.5 min), and the longest median duration of SWS (9 min versus 8 min; Fig. 2 ). The changes in HR after sleep state onset in sleep stage 2, SWS and REM sleep were similar for patients and controls (Fig. 3) . Changes in HRV over time were similar for patients and controls in REM and SWS, but a less marked decrease in LF/HF ratio was seen in patients during sleep state 2 (P < 0.05).
HR and HRV during sleep state transitions
Heart rate increase during the transition from NREM to wake was significantly lower in the NC than in the control group (Fig. 4) . The change in the sympathovagal balance was similar for both groups. HR and HRV increase during the transition from NREM to REM sleep did not differ between the groups.
DI SCUSSION
This study found that narcolepsy is associated with a continuously elevated HR with unchanged HRV during sleep. Neither shorter sleep state duration nor frequent stage transitions could explain the higher HR in narcolepsy: (i) the effects of sleep state duration on HR were intact; (ii) the increases in HR in patients following transitions were similar to controls (NREM to REM) or even less marked (NREM to wake). Taken together, these results suggest that the continuously elevated HR during sleep is not due to sleep fragmentation, but more probably reflects a direct effect of hypocretin deficiency.
Autonomic control during sleep
Physiological NREM sleep is characterized by a progressive increase in parasympathetic tone and a decrease in sympathetic activity, resulting in a decrease of HR and blood pressure (Cortelli et al., 2012; Somers et al., 1993; Stein and Pu, 2012) . Conversely, autonomic activity becomes unstable during REM sleep with irregular activation and deactivation of the central autonomic network, resulting in a relative increase of HR and blood pressure (Cortelli et al., 2012; Somers et al., 1993; Stein and Pu, 2012) . In line with previous work (Grimaldi et al., 2012; Silvani et al., 2013; Sorensen et al., 2013) , this study found that nocturnal HR was elevated in all sleep states without clear HRV changes (Silvani et al., 2013) . In two studies, HR during sleep was not higher in patients with NC: in one older study (Ferinistrambi et al., 1997) NC was diagnosed without proof of hypocretin deficiency and may therefore have introduced diagnostic bias. In the second recent paper, indeed similar HR during sleep states was reported, but at the same time a less marked HR decline from wake to sleep was seen in patients with NC versus controls (Donadio et al., 2014) . Taken together, we believe that there is sufficient evidence for a higher nocturnal HR in NC. In contrast to previous work, this study corrected for effects of apnoea, changes in respiratory variability and sleep fragmentation in NC, allowing us to improve our understanding of its aetiology. Because no differences were found even when these differences were taken into account, we feel that there are no substantial shifts in sympathovagal balance during undisturbed sleep in NC. Not only HR, but also blood pressure were found to be increased during sleep in NC (Dauvilliers et al., 2012; Grimaldi et al., 2012) . Both findings could theoretically be HF, high frequency; HR, heart rate; HRV, heart rate variability; LF, low frequency; LM, leg movements; NC, narcolepsy with cataplexy; REM, rapid eye movement; SWS, slow-wave sleep. *P < 0.05; **P < 0.01; ***P < 0.001.
ª 2014 European Sleep Research Society explained by sleep fragmentation (Grimaldi et al., 2012 ), but we found no effect of sleep state duration on HR, so this explanation is not likely. Previous analysis of coupling of HR and blood pressure responses provided evidence that central feedforward mechanisms are the likely underlying cause of the sleep-related autonomic response in NC (Silvani et al., 2013) . The central autonomic network during NREM sleep may involve the hypothalamic ventrolateral preoptic area, central thermoregulatory and central baroreflex pathways, and command neurons in the pons and midbrain, and is a major determinant of autonomic control during sleep (Niemeijer et al., 2014) . The absence of congruous findings in sympathovagal balance may be explained by the fact that hypocretin neurons affect both sympathetic and parasympathetic outflow (Samson et al., 2005) . Interestingly, this study found that patients with NC tended to have a higher and more variable sleep-related respiratory frequency. These findings warrant further research. It might be postulated that this unstable respiratory frequency during sleep is associated with a decreased chemoreflex sensitivity and hereby explains the increased prevalence of apnoeas in patients with NC (Grimaldi et al., 2014) . To our knowledge, the association between chemoreflex sensitivity and apnoeas has only been demonstrated in hypocretin knockout mice (Nakamura et al., 2007; Williams and Burdakov, 2008) and not in humans so far.
Autonomic control during wakefulness
Interestingly, two studies in NC reported an increased sympathovagal balance during wake (Ferinistrambi et al., 1997; Grimaldi et al., 2010) , whereas this balance was unchanged in two others (Fronczek et al., 2008; Silvani et al., 2013) . Obviously, these discrepancies could result from a type I error. Alternatively, it could be speculated that these differences are explained by differences in vigilance. Disturbed vigilance is one of the key symptoms in NC, and typically fluctuates during the day. Impaired vigilance, if accompanied by 'fighting against sleep', is likely to be accompanied by increased sympathetic outflow (Grimaldi et al., 2010) . More definite conclusions could be drawn if HR changes during wake in NC are related to quantitative assessments of vigilance levels including Sustained Attention to Response Test (Van Schie et al., 2012) . The same holds for total power of HRV, which was found to be increased in one daytime study (Fronczek et al., 2008) but normal in another (Grimaldi et al., 2010) .
Autonomic response to arousing events during sleep
This study found a blunted HR increase in response to awakening from NREM sleep in NC. Similarly, a diminished HR increase after arousal (Sorensen et al., 2013) and leg movements (Dauvilliers et al., 2011; Sorensen et al., 2013) has been reported in NC. HR increases during arousing events are accompanied by an increase in sympathetic tone (Somers et al., 1993) . Accordingly, blunted HR responses to arousal have been reported not only in peripheral autonomic disorders [pure autonomic failure (Freilich et al., 2010 ) and Parkinson's disease (Sorensen et al., 2012) ], but also in central ones [multiple system atrophy (Freilich et al., 2010) and REM sleep behaviour disorder (Sorensen et al., 2012) ].
In view of the absence of signs of peripheral vagal denervation (Ewing et al., 1985; Hublin et al., 1994) and the coupling of HR and blood pressure changes (Silvani et al., 2013) , autonomic alterations in NC probably reflect a central and not a peripheral site of action (Grimaldi et al., 2014) .
Clinical implications
Recent work suggested an increased prevalence of heart diseases and hypertension in NC (Ohayon, 2013 increased cardiovascular risk. Alternatively, this higher risk may result from drug treatment. Further prospective studies are needed to determine whether the autonomic profiles in drug-naive patients may explain the increased propensity to cardiovascular disease.
Limitations
One obvious limitation of our study is the small number of participants. This is the inevitable result of selecting a homogeneous group of recently diagnosed, hypocretin-deficient and drug-naive patients with NC, and we feel that this outweighs the disadvantages of limited group size. The study did therefore not have enough power to detect small differences and we were not able to correct for multiple testing. However, we believe that our conclusions are valid as the results were similar in all sleep states and in line with previous work. PSG was performed only during 1 night. Participants may not have had ample opportunity to get used to the set-up, which may have interfered with their sleeping behaviour. Due to the retrospective set-up, we could not ensure complete blinding of technicians. As a consequence, certain features in NC including sleep fragmentation may have been overreported. As we accounted for the effects of transitions and sleep state durations, we believe that this did not affect our results. A potential limitation is that we did not record for each epoch whether it was associated with arousal or not. Arousals may cause minor transient effects sympathetic tone (Freilich et al., 2010; Somers et al., 1993) . Nevertheless, we believe that this effect will be negligible as we included all epochs during sleep (i.e. on average 860 per subject), and epochs with arousals will only constitute a minority. Moreover, those arousals with major effects on autonomic control will relate to apnoea, leg movements and transitions, factors that we accounted for. Another limitation is the lack of blood pressure measurements, thus preventing us to detail changes in baroreflex sensitivity and central autonomic control (Silvani et al., 2013) .
CONCLUSI ON S
Heart rate in narcolepsy is increased during the entire nocturnal sleep period, and the increase is not due to shorter sleep state duration or frequent transitions. These findings are best explained by an important contribution of hypocretin deficiency per se.
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